CVE-2001-0117

Description

sdiff 2.7 in the diffutils package allows local users to overwrite files via a symlink attack.

1.2

CVSS

Severity: Low

CVSS 2.0 •

EPSS 0.12%

Vendor Advisory immunix.org Vendor Advisory linux-mandrake.com Vendor Advisory redhat.com Vendor Advisory securityfocus.com

Affected: n/a n/a

References

Link	Tags
http://marc.info/?l=bugtraq&m=97916374410647&w=2	mailing list
http://download.immunix.org/ImmunixOS/7.0/updates/IMNX-2000-70-028-01	vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/5914	vdb entry
http://www.securityfocus.com/bid/2191	vdb entry patch vendor advisory
http://www.kb.cert.org/vuls/id/579928	third party advisory us government resource
http://www.linux-mandrake.com/en/security/2001/MDKSA-2001-008.php3	patch vendor advisory
http://www.redhat.com/support/errata/RHSA-2001-116.html	vendor advisory

Frequently Asked Questions

What is the severity of CVE-2001-0117?: CVE-2001-0117 has been scored as a low severity vulnerability.
How to fix CVE-2001-0117?: To fix CVE-2001-0117, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2001-0117 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2001-0117 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.